Organon & Co. OGN
Set alert
13.82 USD -0.02 -0.14%
At close · Nov 2
13.81 -0.01 -0.07%
After hours · Nov 2, 4:00 PM ET
13.82 Day range 13.84
5.69 52-week range 13.84
- YTD
- +92.75%
- 1 year
- +104.74%
- Open
- 13.85
- Prev close
- 13.84
- Mkt cap
- 3.63B
- Vol
- 2.15M
- Avg vol
- 2.58M
- EPS
- 0.78
- P/E
- 17.72
- Div yield
- 0.58%
More statistics
- Low
- 13.82
- High
- 13.84
- Forward P/E
- 3.79
- Beta
- 1.49
- Short ratio
- 8.54
- Inst. own
- 84.58%
- Dividend
- 0.08
- Ex-div date
- Nov 8, 2026
- Earnings
- Feb 11, 2027
- 50-d avg
- 13.74
- 200-d avg
- 11.52
- 1y target
- 10.33
Analyst view
Consensus: hold
Hold
Price target (mean) 10.33 -25.2% downside
Now 13.82
- Target (low)
- 8.00
- Target (mean)
- 10.33
- Target (high)
- 14.00
Ratings (0m) 4 0 buy · 3 hold · 1 sell
- Strong buy0
- Buy0
- Hold3
- Sell0
- Strong sell1
Recommendation trend
- This month 4
- 1 month ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.94645 | 0.88235 – 1.05 | 1.01 | -6.3% | 1.57B | -1.7% | 3 |
| Next quarter | 0.69432 | 0.62 – 0.80797 | 0.63 | +10.2% | 1.55B | +2.7% | 3 |
| Current year | 3.44 | 3.30 – 3.72 | 3.66 | -6.1% | 6.16B | -0.9% | 4 |
| Next year | 3.65 | 3.55 – 3.82 | 3.44 | +6.2% | 6.29B | +2.1% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 29, 2026 | BNP Paribas | Downgrade | Outperform | Neutral |
| Apr 28, 2026 | Piper Sandler | Upgrade | Underweight | Neutral |
| Feb 24, 2026 | Barclays | Maintained | Underweight | Underweight |
| Dec 9, 2025 | Barclays | Initiated | — | Underweight |
| Nov 11, 2025 | JP Morgan | Maintained | Underweight | Underweight |
| Nov 11, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| May 15, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| May 5, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Apr 9, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Feb 14, 2025 | Barclays | Maintained | Overweight | Overweight |
| Feb 14, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Sep 6, 2024 | JP Morgan | Downgrade | Neutral | Underweight |
| May 6, 2024 | Goldman Sachs | Maintained | Neutral | Neutral |
| May 3, 2024 | Goldman Sachs | Maintained | Neutral | Neutral |
| Apr 29, 2024 | Piper Sandler | Maintained | Overweight | Overweight |
| Feb 20, 2024 | Goldman Sachs | Maintained | Neutral | Neutral |
| Nov 22, 2023 | Piper Sandler | Maintained | Overweight | Overweight |
| Nov 3, 2023 | Goldman Sachs | Downgrade | Buy | Neutral |
| Oct 25, 2023 | Piper Sandler | Maintained | Overweight | Overweight |
| Oct 11, 2023 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Sep 21, 2023 | Barclays | Initiated | — | Overweight |
| Aug 9, 2023 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| May 8, 2023 | Morgan Stanley | Maintained | — | Equal-Weight |
| Mar 16, 2023 | Raymond James | Initiated | — | Outperform |
| Nov 4, 2022 | Morgan Stanley | Maintained | — | Equal-Weight |
| Oct 14, 2022 | B of A Securities | Downgrade | Neutral | Underperform |
| Oct 12, 2022 | Morgan Stanley | Maintained | — | Equal-Weight |
| Sep 6, 2022 | Piper Sandler | Upgrade | Neutral | Overweight |
| Aug 5, 2022 | B of A Securities | Downgrade | Buy | Neutral |
| Jul 8, 2022 | Morgan Stanley | Maintained | — | Equal-Weight |
